Should a pregnant patient receive the standard 0.5 mL intramuscular inactivated influenza vaccine during the third trimester?

Yes, pregnant patients should receive the standard 0.5 mL intramuscular inactivated influenza vaccine during the third trimester.

Pregnant patients in the third trimester should receive the inactivated influenza vaccine (IIV) at the standard 0.5 mL intramuscular dose, and early vaccination during July-August can be specifically considered for those in the third trimester to provide passive protection to their infants during the first months of life when they are too young to be vaccinated 1, 2.

Key Recommendations

Vaccine Type and Timing

• Any licensed, age-appropriate inactivated influenza vaccine (IIV) or recombinant influenza vaccine (RIV) can be used during any trimester of pregnancy 3, 1
• The live attenuated influenza vaccine (LAIV) is contraindicated during pregnancy 4, 3, 1
• For third trimester patients specifically, vaccination during July-August is encouraged (unlike first/second trimester patients where waiting until September-October is preferred) because maternal antibodies will transfer to the infant and provide protection during the vulnerable first 6 months of life 1, 2

Dose Specifications

The standard adult dose is 0.5 mL intramuscular for all inactivated influenza vaccines in pregnant patients, regardless of trimester 3, 1. This is the same dose used for non-pregnant adults.

Clinical Rationale

Maternal Protection

Pregnant patients face significantly elevated risk for severe influenza illness, hospitalization, and death, particularly during the second and third trimesters 3, 1. This heightened vulnerability makes vaccination a critical protective measure.

Infant Protection

Vaccination during pregnancy, especially the third trimester, provides multiple layers of protection for the newborn:

• Transplacental antibody transfer provides passive immunity to infants during their first months of life when they cannot yet be vaccinated 4, 1
• Breast milk contains higher levels of influenza-specific IgA antibodies when mothers are vaccinated during the third trimester 4
• Studies demonstrate that infants born to vaccinated mothers have better influenza-related health outcomes compared to infants of unvaccinated mothers 4

Safety Profile

Established Safety Data

The safety evidence is robust and reassuring:

• No association with adverse pregnancy outcomes including spontaneous abortion, preterm birth, or congenital malformations across multiple large studies 3, 1
• One VSD study from 2010-11/2011-12 seasons noted an association with miscarriage when H1N1pdm09-containing vaccine was given after prior season H1N1pdm09 vaccination, but a larger follow-up study found no increased risk during 2012-15 seasons 3, 1
• The evidence base is strongest for traditional egg-based IIVs, with growing safety data for newer formulations (cell culture-based, recombinant) 1

Important Caveat

While safety data for first trimester vaccination is more limited than for later trimesters, no studies have identified safety concerns with vaccination during any trimester 3, 1. The third trimester has the most extensive safety documentation and the added benefit of optimal infant protection.

Practical Implementation

Vaccine Selection

• Use any available age-appropriate IIV or RIV (trivalent or quadrivalent formulations are acceptable) 1
• Thimerosal-free formulations are preferred when available, though this is a preference rather than an absolute requirement 2
• Standard-dose vaccines are appropriate; high-dose and adjuvanted formulations are reserved for adults ≥65 years 3, 1

Administration

• Standard intramuscular injection in the deltoid muscle
• Can be given simultaneously with other indicated vaccines (such as Tdap if not yet received during this pregnancy)
• No special precautions or monitoring required beyond standard vaccine administration protocols

Timing Considerations

For third trimester patients presenting in July-August: vaccinate immediately rather than waiting, as this maximizes infant protection 1, 2. For patients presenting later in pregnancy or during traditional flu season (September-March), vaccinate at the first available opportunity.

Common Pitfalls to Avoid

1. Do not delay vaccination waiting for "the right time" - any time during the third trimester is appropriate, and earlier is better for infant protection
2. Do not use LAIV (nasal spray vaccine) - only inactivated or recombinant vaccines are appropriate during pregnancy
3. Do not withhold vaccination due to concerns about first trimester safety data - while third trimester has more data, vaccination in any trimester is safe and recommended
4. Do not assume prior vaccination eliminates the need for annual vaccination - influenza vaccine is needed every season

The evidence consistently supports that vaccination during the third trimester provides dual protection for both mother and infant with an excellent safety profile, making it a clear clinical recommendation 3, 1, 2.